SCHEMBL6019474

SCHEMBL6019474

O=C(N[C@@H](CCCNC1CCCc2cccnc21)C(=O)NCc1cccc2ccccc12)c1ccc(CNCc2ncc[nH]2)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.45
HDAC6 Q9UBN7 2/20 0.45
CXCR4 P61073 2/20 0.39
KDM1A O60341 8/20 0.37
MAOA P21397 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC2 Q92769 1/20 0.37
KDM1B Q8NB78 1/20 0.36
SLC40A1 Q9NP59 1/20 0.36
TAOK1 Q7L7X3 1/20 0.34
TAOK3 Q9H2K8 1/20 0.34
NTMT1 Q9BV86 1/20 0.34
MCHR1 Q99705 1/20 0.34
CCKBR P32239 1/20 0.34
PADI4 Q9UM07 1/20 0.34
PADI2 Q9Y2J8 1/20 0.34
MAPK14 Q16539 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6018123 0.90 HDAC1 (0.55) HDAC1HDAC6CXCR4KDM1AMAOA
SCHEMBL6019439 0.90 SLC40A1 (0.36) HDAC1HDAC6CXCR4SLC40A1NTMT1
SCHEMBL6018332 0.89 SLC40A1 (0.38) HDAC1HDAC6CXCR4SLC40A1NTMT1
SCHEMBL6018137 0.87 HDAC1 (0.53) HDAC1HDAC6CXCR4KDM1AMAOA
SCHEMBL6018195 0.85 CXCR4 (0.46) HDAC1CXCR4KDM1AMAOAHDAC3
SCHEMBL6658429 0.82 CXCR4 (0.51) HDAC1HDAC6CXCR4TAOK1TAOK3
SCHEMBL6018202 0.81 CXCR4 (0.47) HDAC1HDAC6CXCR4SLC40A1MAPK14
SCHEMBL6681750 0.81 HDAC1 (0.54) HDAC1HDAC6CXCR4KDM1AMAOA
SCHEMBL6018112 0.81 HDAC1 (0.44) HDAC1HDAC6CXCR4KDM1AKDM1B
SCHEMBL6652655 0.81 CXCR4 (0.43) HDAC1CXCR4HDAC3HDAC2SLC40A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7098215-B2 Nitrogenous compounds and antiviral drugs containing the same KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) 2006-08-29 US disclosed
US-20040157818-A1 Cxcr4-antagonistic drugs composed of nitrogen-containing compound KUREHA CORPORATION (JP) 2004-08-12 US disclosed
US-20040092556-A1 Nitrogenous compounds and antiviral drugs containing the same KUREHA CORPORATION (JP) 2004-05-13 US disclosed
EP-1273571-A1 NITROGENOUS COMPOUNDS AND ANTIVIRAL DRUGS CONTAINING THE SAME Kureha Chemical Industry Co., Ltd. (JP) 2003-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092556-A1 Nitrogenous compounds and antiviral drugs containing the same NSUN2, ZC3HAV1L, PNP HDAC1 651/4885HDAC6 3064/4885CXCR4 2185/4885
US-20040157818-A1 Cxcr4-antagonistic drugs composed of nitrogen-containing compound CXCR4, CXCR1, CXCR2 HDAC1 1092/4885HDAC6 1799/4885CXCR4 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.